Total Funding
80
61
Total FundingSeries A raised
Growth Score
-5 pts
Heat Score
8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
30874
Orangebiomed is a healthcare startup with cutting-edge diabetes management technology.
- Eunyoung Park: Co-Founder and Chief Research Officer
- Yeaseul Park: Co-Founder and CEO
About the Company
Orange Biomed is a startup in the bio-healthcare sector that offers OBM rapid A1c, a portable medical device designed for measuring glycated hemoglobin (HbA1c) through the use of microfluidic technology. The OBM at-home A1C device serves as an accessible and cost-effective solution for improved diabetes management. This home-based medical device
addresses the critical gap between hospitals and patients' residences by reducing healthcare expenses and enhancing the quality of life for individuals with diabetes. It features a user-centered design that incorporates cutting-edge technology, delivering effective healthcare solutions for managing diabetes.
